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Warty carcinoma of the penis is an unusual neoplasm and a variant of penile squamous cell carcinoma.
As with other types of penile cancer, risk factors include human papillomavirus infection, poor personal
hygiene, and being uncircumcised. The typical case is an exophytic mass arising from the glans penis,
frequently large (4-5 cm), and with invasion into corpus spongiosum. The diagnosis is typically made by
tumor biopsy. Treatment depends on the stage of disease and includes partial vs total penectomy, with or
without prophylactic or therapeutic bilateral lymphadenectomy. We present an unusual case of penile
cancer in a 19-year-old patient.
 2014 The Authors. Published by Elsevier Inc. All rights reserved.Introduction
Warty carcinoma of the penis is an unusual neoplasm and a
variant of penile squamous cell carcinoma.1 The typical case is an
exophytic mass arising from the glans penis, frequently large
(4-5 cm), and with invasion into corpus spongiosum. Microscopic
features representative of warty carcinoma are hyperkeratosis,
papillomatosis, parakeratosis, and prominent koilocytosis with nu-
clear pleomorphism.1 Clinically, patients complain of a growing
mass on the distal penis, ulceration, bleeding, and discharge. The
diagnosis is typically made by tumor biopsy. Staging may include
urethroscopy and computed tomography (CT) or magnetic reso-
nance imaging (MRI). Treatment depends on the stage of disease and
includes partial vs total penectomy, with or without prophylactic or
therapeutic bilateral lymphadenectomy.
Case presentation
An otherwise healthy 19-year-old circumcised man with a his-
tory of burns to the penis as a toddler presented for evaluation of a
penile mass present for approximately 8 months. He denied being
sexually active. Evaluation for human immunodeﬁciency virus
infection (enzyme-linked immunosorbent assay) was negative.
Physical examination revealed a large fungating penile mass with a
discharge. The lesion almost completely replaced the extracorporalBY-NC-ND license (http://
ou).
Published by Elsevier Inc. All righpenis and extended to the base of the penis. There was no palpable
inguinal lymphadenopathy, and the remainder of the genitourinary
examination was unremarkable. Abdominal and pelvic CT revealed
only bilateral inguinal adenopathy. No evidence of distant meta-
static disease was noted. MRI of the penis revealed an approxi-
mately 4-cm verrucous penile mass that completely replaced the
glans penis and abutted the tip of the corporal bodies. Partial
penectomy was the initial therapeutic step. After resection, the
neourethra and corporal bodies were ﬂush with the skin of the
penoscrotal junction.
The surgical pathologic diagnosis was well-differentiated
“warty” (condylomatous) squamous cell carcinoma obliterating
the glans penis. Grossly, the specimen consisted of an unrecogniz-
able glans penis and a portion of relatively spared penile shaft. The
exophytic verrucous lesion obliterating the glans penis had an
arborizing papillomatous cut surface (Fig. 1). The urethral ostium
was also involved. Microscopically, the lesion was papillomatous
with thin ﬁbrovascular cores. Acanthosis, parakeratosis, and koilo-
cytosis were prominent throughout, with inﬁltrating nests of tumor
at the base (Fig. 2).
One year later, the patient was electively scheduled for stage I
urethroplasty with buccal mucosal grafting due to stenosis at the
urethrocutaneous meatus. The delay in urethroplasty was due to
nonmedical, administrative, and personal factors. Five months
later, evaluation of urinary obstructive symptoms revealed a
0.5  0.5 cm papillary urethral lesion. Resection of this lesion
necessitated simultaneous placement of another buccal mucosal
graft. The surgical pathology from this resection revealed only
focal condylomatous changes, underlying ﬁbrosis, and chronicts reserved.
Figure 1. (A) Verrucous lesion obliterating the glans penis. (B) Cut surface shows papillary architecture.
Figure 2. (A) Arborizing papillomatous architecture with thin ﬁbrovascular cores (scanning magniﬁcation). (B) Papillomatosis, koilocytosis, and parakeratosis are evident at the
surface (left), whereas invasion and reactive stroma are seen at the base of the lesion (right; 10).
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phalloplasty using a radial forearm ﬂap, but he has failed to
complete his preoperative preparation and has been lost to
follow up.
Discussion
Carcinoma of the penis is rare in developed countries. The
highest incidence is reported in Asia (China, Vietnam, Sri Lanka,
Burma, and India), Africa (Uganda), and Latin America (Mexico).
The average age at presentation is late 50s-60s. The etiology is
typically multifactorial and includes poor hygiene, pre-existing
condyloma acuminatum, squamous intraepithelial lesions with
warty features, and human papillomavirus infection. Approxi-
mately 40% of penile cancers have been shown to be attributable
to human papillomavirus types 16 and 18. Type 16 has preferen-
tially been associated with a small subset of penile cancers,
including basaloid, mixed warty-basaloid, and pure warty squa-
mous carcinomas.1 Most penile neoplasms are squamous cell
carcinomas, of which there are multiple variants (Table 1). They
usually demonstrate 1 of 3 growth patterns: superﬁcial spreading
with minimal stromal invasion, vertical growth with deep inva-
sion, or exophytic growth. Warty carcinomas comprise 5%-10% of
all penile carcinomas.2 The diagnosis of warty carcinoma isTable 1
Variants of penile squamous cell carcinoma
Variants of penile squamous carcinoma
Squamous cell carcinoma, not other speciﬁed
Basaloid carcinoma
Warty (condylomatous) carcinoma
Papillary carcinoma
Verrucous carcinoma
Pseudohyperplastic carcinoma
Sarcomatoid (spindle cell) carcinoma
Acantholytic carcinomaconﬁrmed by histology, which is essential before deﬁnitive
treatment. Urethroscopy may also be considered. MRI of the penis
to identify invasion into the corpora cavernosa or spongiosum is
helpful when the depth and extent of tumor remain unclear on
physical examination. Abdominal and pelvic CT or MRI may be
useful to exclude metastatic disease.
Partial penectomy with a 2-cm proximal resection margin was
traditionally recommended for adequate local control of T1-T2 tu-
mors and remains the gold standard. However, penile length
sparing by decreasing the margin of resection is now acceptable in
select cases. Alternative penile-sparing techniques include Mohs
micrographic surgery, laser ablation, and radiation therapy (RT).
Mohs surgery does not offer much beneﬁt over surgical excision
with intraoperative frozen section because of high risk of recur-
rence,5 whereas laser ablation offers comparable extirpative results
with additional functional beneﬁts. Using the neodymium:yttrium-
aluminum-garnet laser in conjunction with tumor base biopsies to
ensure negative margins, Frimberger3 reported a mere 7% recur-
rence rate at 47 months for 29 patients. Laser ablation has also been
associated with a 75% rate of resumption of sexual activity and a
78% rate of patient satisfaction. In select cases, RT may be consid-
ered, but technical challenges exist related to possible need for
circumcision and penile immobilization. Also, with 5-year local
control rates of only 44%-70%, RTappears inferior to surgical or laser
extirpation. Because penile squamous cell carcinoma is relatively
radioresistant, the efﬁcacy of RT is limited. Thus, if chosen, high
doses of RT are required, which predispose to local complications
such as desquamation, urethral stenosis, soft-tissue necrosis,
edema, and secondary infection.3,4 Management of stage T3-T4
disease is more difﬁcult because most patients will have exten-
sive regional lymph node metastases requiring inguinal lympha-
denectomy in addition to partial or total penectomy. For patients
with unresectable bulky inguinal adenopathy, neoadjuvant
chemotherapy or chemoradiotherapy may be considered. Response
rates to neoadjuvant chemotherapy in this setting range from
31% to 50%, but long-term survival rates are generally poor. Fortu-
nately, there have been no reported cases of metastasis from
Y. Tarbunou et al. / Urology Case Reports 2 (2014) 79e81 81verrucous carcinomas. So, such aggressive adjuvant therapy is not
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